Plain-English translation of NCT02735057 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a combination treatment for esophageal cancer in older adults (age 75 and above). The treatment combines two chemotherapy drugs— and paclitaxel—delivered at the same time as radiation therapy. Researchers want to find the best doses of both the medication and radiation that work well and are tolerable for elderly patients.
A successful study in the Netherlands showed that this combined approach can shrink tumors and improve survival in esophageal cancer patients. However, doctors don't yet know the optimal doses of each component, especially for elderly patients who may need different dosing than younger patients. This trial aims to find those safe and effective doses.
You likely qualify if…
You likely don't qualify if…
In the first phase of the trial, you would receive chemotherapy infusions combined with radiation therapy over several weeks. The study starts with lower doses and gradually increases them in small groups of patients to find the safest effective dose. Once the best dose is determined, the trial continues to a second phase where more patients receive that dose to see how well it works. Throughout the trial, you would have regular clinic visits, blood tests, and imaging scans to monitor how you're responding and to check for side effects.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
France